UnitedHealth, Dow Jones & Company and Insiders Scoop
Digest more
When CFRA’s Paige Meyer slapped a “sell” rating on UnitedHealth Group Inc. in February, she was the lone analyst out of 30 tracked by Bloomberg with a negative view of the company.
UNH's dip to $250 offers a strong buy opportunity with solid revenue growth, resilient dividends, and historic low P/E.
UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.
StockStory.org on MSN5d
Why UnitedHealth (UNH) Stock Is Trading Lower TodayWhat Happened? Shares of health insurance company UnitedHealth (NYSE:UNH) fell 16% in the morning session after the Wall Street Journal reported that the Justice Department was investigating the company for possible Medicare fraud.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum ...
6don MSN
Stephen Hemsley is again leading Minnesota’s largest company as it grapples with financial uncertainties and increasing regulatory scrutiny
UnitedHealth Group announced Tuesday that CEO Andrew Witty is stepping down for “personal reasons,” with the company providing no further details on the abrupt departure. Former CEO Stephen Hemsley, who has been with the healthcare conglomerate for 28 years, will return to the top role effective immediately.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy UnitedHealth? Access our full analysis report here ...
UnitedHealth stock price was the biggest gainer in the Dow Jones Index on Monday as the beleaguered health insurance giant fights to win back investor confidence through insider buybacks. The stock closed the session at +8.